BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21741436)

  • 1. Dietary flavones and flavonones display differential effects on aromatase (CYP19) transcription in the breast cancer cells MCF-7.
    Li F; Ye L; Lin SM; Leung LK
    Mol Cell Endocrinol; 2011 Sep; 344(1-2):51-8. PubMed ID: 21741436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression.
    Wang Y; Man Gho W; Chan FL; Chen S; Leung LK
    Br J Nutr; 2008 Feb; 99(2):303-10. PubMed ID: 17761019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells.
    Wang Y; Lee KW; Chan FL; Chen S; Leung LK
    Toxicol Sci; 2006 Jul; 92(1):71-7. PubMed ID: 16611627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells.
    Prosperi JR; Robertson FM
    Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):55-70. PubMed ID: 16997132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary administration of the licorice flavonoid isoliquiritigenin deters the growth of MCF-7 cells overexpressing aromatase.
    Ye L; Gho WM; Chan FL; Chen S; Leung LK
    Int J Cancer; 2009 Mar; 124(5):1028-36. PubMed ID: 19065667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells.
    Sanderson JT; Hordijk J; Denison MS; Springsteel MF; Nantz MH; van den Berg M
    Toxicol Sci; 2004 Nov; 82(1):70-9. PubMed ID: 15319488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
    Kinoshita Y; Chen S
    Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The citrus flavonone hesperetin inhibits growth of aromatase-expressing MCF-7 tumor in ovariectomized athymic mice.
    Ye L; Chan FL; Chen S; Leung LK
    J Nutr Biochem; 2012 Oct; 23(10):1230-7. PubMed ID: 22209285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of luteolin on estrogen biosynthesis in human ovarian granulosa cells by suppression of aromatase (CYP19).
    Lu DF; Yang LJ; Wang F; Zhang GL
    J Agric Food Chem; 2012 Aug; 60(34):8411-8. PubMed ID: 22838964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCAAT/enhancer binding protein delta up-regulates aromatase promoters I.3/II in breast cancer epithelial cells.
    Kijima I; Ye J; Glackin C; Chen S
    Cancer Res; 2008 Jun; 68(11):4455-64. PubMed ID: 18519709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grape seed extract is an aromatase inhibitor and a suppressor of aromatase expression.
    Kijima I; Phung S; Hur G; Kwok SL; Chen S
    Cancer Res; 2006 Jun; 66(11):5960-7. PubMed ID: 16740737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic mechanisms regulating CYP19 transcription in human breast adipose fibroblasts.
    Knower KC; To SQ; Simpson ER; Clyne CD
    Mol Cell Endocrinol; 2010 Jun; 321(2):123-30. PubMed ID: 20211687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyul-Tong-Ryung suppresses PMA-induced MMP-9 expression by inhibiting AP-1-mediated gene expression via ERK 1/2 signaling pathway in MCF-7 human breast cancer cells.
    Kim KS; Yao L; Lee YC; Chung E; Kim KM; Kwak YJ; Kim SJ; Cui Z; Lee JH
    Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):600-6. PubMed ID: 20131957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A positive feedback pathway of estrogen biosynthesis in breast cancer cells is contained by resveratrol.
    Wang Y; Ye L; Leung LK
    Toxicology; 2008 Jun; 248(2-3):130-5. PubMed ID: 18462857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of Nobiletin, Hesperetin, and Letrozole in a combination on the activity and expression of aromatase in breast cancer cells.
    Rahideh ST; Keramatipour M; Nourbakhsh M; Koohdani F; Hoseini M; Shidfar F
    Cell Mol Biol (Noisy-le-grand); 2017 Feb; 63(2):9-13. PubMed ID: 28364779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
    Rubin GL; Zhao Y; Kalus AM; Simpson ER
    Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive and negative transcriptional regulation of aromatase expression in human breast cancer tissue.
    Chen S; Ye J; Kijima I; Kinoshita Y; Zhou D
    J Steroid Biochem Mol Biol; 2005 May; 95(1-5):17-23. PubMed ID: 15955695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
    Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichostatin A down-regulates CYP19 transcript and protein levels in MCF-7 breast cancer cells.
    Łuczak MW; Jagodziński PP
    Biomed Pharmacother; 2009 May; 63(4):262-6. PubMed ID: 18602794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mechanism of inhibition of sodium butyrate on activation of tumor associated aromatase promoters].
    Zhou JF; Liu WL; Chen G; Lu YP; Ma D
    Ai Zheng; 2002 Dec; 21(12):1283-7. PubMed ID: 12520731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.